---
title: "Testing Claims Comprehensibility in Rx Cardiology | Minds"
canonical_url: "https://getminds.ai/use-cases/claims-comprehensibility-testing-for-regulatory-affairs-manager-in-rx-cardiology-pharma"
last_updated: "2026-10-01T09:35:29.815Z"
meta:
  description: "Test promotional claims for cardiovascular drugs for comprehensibility among cardiologists prior to HWG approval with Minds."
  "og:description": "Test promotional claims for cardiovascular drugs for comprehensibility among cardiologists prior to HWG approval with Minds."
  "og:title": "Testing Claims Comprehensibility in Rx Cardiology | Minds"
  "twitter:description": "Test promotional claims for cardiovascular drugs for comprehensibility among cardiologists prior to HWG approval with Minds."
  "twitter:title": "Testing Claims Comprehensibility in Rx Cardiology | Minds"
---

Minds

August 13, 2026·Use-case·Minds Team # **Testing Claims Comprehensibility in Rx Cardiology** Regulatory affairs managers in Rx cardiology test the professional interpretation and comprehensibility of promotional claims using simulated cardiologists. Minds delivers directional feedback before market entry to minimize HWG risks. Discover the methodology in the platform. Regulatory affairs managers in Rx cardiology use Minds to test the technical comprehensibility and rhetorical impact of promotional claims among German cardiologists before formal approval. The platform simulates the reading behavior and professional interpretation of hospital specialists and office-based cardiologists while factoring in the requirements of the German Therapeutic Products Act (HWG). These directional target audience simulations identify potential misinterpretations, medical skepticism, and fair-trade legal pitfalls early in the drafting process, long before physical panels or market tests are launched. ## The job to be done In the pharmaceutical industry, particularly with prescription cardiovascular medications, regulatory affairs managers operate under intense pressure. When launching new therapies for heart failure, hypertension, or thrombosis, complex clinical trial results must be translated into concise promotional statements for medical professionals. The central task is ensuring that scientific messaging is legally compliant within HCP communications while being accurately understood by cardiologists. Section 3 of the German Therapeutic Products Act (HWG) strictly prohibits misleading statements. If a claim is misinterpreted by an office-based cardiologist or a senior attending physician in cardiology, companies face competitor warnings, regulatory objections, or severe reputational damage. Stakeholders in brand management and medical affairs expect rapid sign-off to keep sales timelines on track, while the legal department demands maximum risk mitigation. Consequently, the regulatory affairs manager must strike the exact linguistic balance: scientifically precise, legally defensible, and immediately understandable in daily clinical practice. Each wording round also has to survive a long internal chain: medical affairs, legal, brand management, and frequently a global headquarters team working from an English master claim. Every handover produces new phrasing variants, and the regulatory affairs manager is left proving that a shortened German sentence still says exactly what the endpoint data supports. Without early evidence of how a cardiologist actually reads that sentence, the proof rests on internal opinion, and the argument is settled by whoever holds seniority in the review meeting rather than by the audience the claim is written for. ## What today's workflow looks like (and where it breaks) The traditional process for reviewing promotional claims in cardiology is characterized by rigid feedback loops and high overheads. When the marketing agency delivers new drafts, legal and regulatory affairs review them manually. To understand how specialist physicians perceive these statements, companies occasionally turn to market research agencies, physician advisory boards, or physical HCP panels. In practice, however, this approach runs into clear limits. Recruiting practicing cardiologists in Germany is extremely difficult and involves high honoraria because the time windows of hospital and office-based physicians are severely restricted. Obtaining qualitative feedback often takes several weeks. Moreover, sample sizes in traditional focus groups are small, making generalizability difficult. Due to time and cost constraints, many teams skip qualitative pre-testing during early drafting phases and rely purely on internal legal assessments. This frequently leads to two extreme outcomes: either claims are diluted so heavily out of excessive caution that they lose all commercial impact, or inadvertently ambiguous phrasing remains in the copy, causing legal disputes under competition law only after launch. ## The Minds workflow With Minds, regulatory affairs managers integrate an iterative simulation methodology directly into their weekly approval workflow. The process breaks down into the following structured steps: - Creating the target audience profile: Define specific audience personas within the workspace, such as office-based cardiologists specializing in heart failure alongside senior hospital cardiologists in Germany. - Uploading the knowledge base: Import planned promotional claims, summary of product characteristics (SmPC), trial results, and draft marketing materials as text or documents. - Configuring test design: Set evaluation criteria for the simulation, focusing on comprehensibility, scientific credibility, and nuanced perception of relative versus absolute risk reductions. - Running synthetic evaluation: Minds simulates the professional reaction and reading behavior of defined target groups, taking into account the regulatory context under the German Therapeutic Products Act (HWG). - Analyzing diagnostic reports: Review generated evaluations for ambiguous terminology, potential misinterpretations, and medical objections raised by HCP segments. - Copy optimization: Refine claims within the approval team based on the directional insights gathered. - Re-simulation: Re-run tests in the same workspace to compare revised copy variations directly. - Compliance documentation: Export results as an evaluation foundation for internal alignment between regulatory affairs, medical affairs, and marketing. ## Sample output A typical diagnostic report in Minds illustrates the type of insights regulatory affairs managers can leverage for decision-making. Suppose a draft for a new chronic heart failure medication contains the claim: _Leads to a significant reduction in cardiovascular mortality compared to standard beta-blocker therapy._ On a qualitative level, the simulation reveals that simulated hospital cardiologists interpret this phrasing significantly differently. While hospital physicians specifically ask for absolute risk reduction metrics, office-based cardiologists partially interpret the statement as suggesting the drug should replace beta-blockers entirely rather than serving as an add-on therapy. From an HWG perspective, the analysis uncovers that using the word _significant_ without directly stating the p-value and underlying endpoint could be flagged as potentially misleading. The system provides concrete text diagnostics highlighting which words trigger skepticism and where clarification is necessary to eliminate misunderstandings among healthcare professionals. The report separates the points where both simulated segments agree from the points where they diverge. That distinction matters for the approval decision: an objection raised only by hospital specialists can often be answered in the detail aid, whereas a reading that both segments share travels with the claim into every detailing conversation and usually calls for rewriting the sentence itself. ## Why this beats the alternative Minds offers decisive advantages over traditional market research approaches and purely manual legal reviews. The key differentiator is that Minds simulates the reading behavior and technical interpretation of German cardiologists with explicit consideration of the German Therapeutic Products Act (HWG). Instead of waiting weeks for feedback from overburdened medical practices or spending high recruitment fees per specialist, the platform enables unlimited, rapid testing cycles at a fraction of the cost of a traditional panel. Regulatory affairs managers no longer have to choose between time-consuming field studies and uncertain guesswork. They gain an agile testing environment to sharpen claims legally and linguistically before submission. However, methodological boundaries apply: Minds provides directional feedback for the concept and phrasing phase. For representative pricing tests, legally required pharmacovigilance studies, or final regulatory submissions, physical recruitment and formal legal review processes remain indispensable. ## Next step Test your pharmaceutical promotional claims for comprehensibility and compliance before sign-off. Learn how synthetic target audience simulations can accelerate alignment across regulatory, medical, and marketing teams. Get started directly in the platform at [getminds.ai](https://getminds.ai/?register=true) and request a methodology deep dive for your team. ## **Frequently asked questions**### **How does Minds support regulatory affairs managers in testing claims?** Minds simulates the professional interpretation of German cardiologists regarding promotional claims, accounting for the German Therapeutic Products Act (HWG). This helps regulatory affairs managers identify ambiguous phrasing and medical misinterpretations before core messages go to legal approval or print. ### **What does simulated target audience analysis replace in the sign-off process?** Minds replaces time-consuming preliminary interviews and costly focus groups with specialists during the concept phase. For final legally binding opinions, regulatory filings, or clinical approval processes, established legal and clinical procedures remain essential. ### **How quickly can cardiology claims be evaluated?** Evaluation takes place directly within the platform in continuous iterations. Once drafts and target audience profiles are uploaded, structured feedback logs are available immediately, allowing phrasing to be adjusted directly within the team. ### **How are data privacy and corporate data handled?** Deployment and data processing take place on European infrastructure. Individual privacy and governance requirements regarding confidentiality and workspace configuration should be reviewed prior to setting up the workspace. [Minds](https://getminds.ai/)© 2026 Minds. Your target audience. AI-driven and grounded in transparent evidence. Build within minutes. [Minds on X (Twitter)](https://x.com/mindsai_co) [Minds on LinkedIn](https://www.linkedin.com/company/mindsaicompany/) [Minds on Instagram](https://www.instagram.com/getminds.ai/)Minds is part of [![ESOMAR](https://getminds.ai/images/newsroom/logos/esomar-logo.svg)ESOMAR](https://esomar.org/) [![GreenBook](https://getminds.ai/images/newsroom/logos/greenbook.svg)GreenBook Directory](https://greenbook.org/company/Minds) [![Insight Platforms](https://getminds.ai/images/newsroom/logos/insight-platforms.png)Insight Platforms](https://www.insightplatforms.com/platforms/minds/) [![Capterra](https://getminds.ai/images/newsroom/logos/capterra.svg)Capterra](https://www.capterra.com/p/10046203/Minds/) [![G2](https://getminds.ai/images/newsroom/logos/g2.svg)G2](https://www.g2.com/products/minds/reviews) [![CSSDA Best UX Design Award](https://getminds.ai/images/newsroom/logos/cssda-best-ux-award.png)CSSDA Best UX Design Award](https://www.cssdesignawards.com/) [![CSSDA Best Innovation Award](https://getminds.ai/images/newsroom/logos/cssda-best-innovation-award.png)CSSDA Best Innovation Award](https://www.cssdesignawards.com/) [![CSSDA Best UI Design Award](https://getminds.ai/images/newsroom/logos/cssda-best-ui-award.png)CSSDA Best UI Design Award](https://www.cssdesignawards.com/)